Background: Early identification of individuals at high risk of developing neurodegenerative diseases is essential for timely preventive intervention. However, simple methods that can be used for risk assessment in general practice are lacking. Methods: Within the population-based Rotterdam Study, we used the Purdue Pegboard Test (PPT) to assess manual dexterity in 4,856 persons (median age 70 years, 58% women) free of parkinsonism and dementia between 2000 and 2004. We followed these persons until January 1, 2012 for the onset of neurodegenerative diseases (defined as first diagnosis of parkinsonism or dementia). We determined the association of PPT scores with incident neurodegenerative disease, adjusting for age, sex, study cohort, level of education, smoking, preferred hand, parental history, memory complaints, and Mini-Mental State Examination. Furthermore, we determined the incremental predictive value of PPT, expressed as change in risk classification and discrimination. Results: During follow-up (median 9.2 years), 277 participants were diagnosed with a neurodegenerative disease (227 with dementia and 50 with parkinsonism). Lower PPT scores were associated with higher risk of incident neurodegenerative diseases (hazard ratio [HR] = 1.28, 95% confidence interval [CI]: 1.18-1.41) and improved discrimination of incident neurodegenerative diseases. We also observed significant associations of PPT scores separately with incident dementia (HR = 1.25; 95% CI: 1.14-1.39]) and incident parkinsonism (HR = 1.41; 95% CI: 1.19-1.67). Conclusions: A rapid, nonlaboratory test of manual dexterity may help to identify persons at high risk for neurodegenerative diseases. This highlights the importance of motor function in the preclinical phase of both dementia and parkinsonism and may aid in selecting individuals for refined screening and neuroprotective trials.
Neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD) constitute a major social and economic burden on the population. Due to a rapidly aging population, this is projected to quadruple during the coming decades (1, 2) , unless preventive or curative treatments can be established. However, development of disease-modifying therapies is hampered by the advanced pathological disease stage at which patients with a neurodegenerative disease receive a clinical diagnosis (3) . Therefore, measures that allow early diagnosis or risk stratification early in the disease process are urgently needed.
Development of simple, nonlaboratory algorithms to identify community-dwelling persons who are at high risk of neurodegenerative diseases would enable referral of these persons to a neurologic or geriatric clinic for further clinical work-up for AD, PD, and other neurodegenerative diseases. Subsequently, individuals at highest risk of neurodegenerative diseases could be monitored for symptom onset to receive early symptomatic treatment or, alternatively, be enrolled in preventive or therapeutic trials. In the future, once treatment options become available that can effectively slow down or halt disease progression, early identification of neurodegenerative disease patients would enable timely initiation of disease-modifying therapies.
Impaired motor function is a hallmark of parkinsonism, and at the same time is increasingly recognized as an important feature of deteriorating brain function in dementia. In community-dwelling elderly adults, gait abnormalities and parkinsonian signs predict dementia (4, 5) , similarly to cognitive tests (6) , and a combination of slow gait and cognitive complaints (7, 8) . As a complex trait that requires integration of motor and cognitive skills, loss of manual dexterity embodies the phenotypical overlap of neurodegenerative diseases (9) (10) (11) . We hypothesized that manual dexterity may deteriorate at an early stage of disease and that a simple test of manual dexterity could therefore predict onset of parkinsonism and dementia in the community. We prospectively tested our hypothesis in a large cohort of community-dwelling individuals aged 55 years and older.
Methods
The study was embedded in the Rotterdam Study (RS-I), a large, prospective, population-based study in the Netherlands (12, 13) . In 1990, inhabitants of the well-defined Ommoord district in the city of Rotterdam who were aged 55 years and older were invited to participate, and 7,983 individuals agreed (first subcohort). In 2000, all inhabitants who had become 55 years of age and older, or moved into the study district since the start of the study, were invited to be included in the Rotterdam Study, and 3,011 agreed (second subcohort). The cohort was further extended in 2006 (third subcohort) to 14,926 participants (overall response 72.0%). By 2012, the first subcohort had five visits (mean interval between visits: 5 years), whereas the second subcohort had three visits. The third subcohort had not had a follow-up visit yet; therefore, we only included the first two subcohorts for this report.
Manual dexterity assessment was introduced at the fourth follow-up visit for the first subcohort (2002) (2003) (2004) ; n = 2,796) and at the first visit for the second subcohort (2000-2002; n = 2,274); we will refer to this assessment as baseline. Participants were extensively screened for parkinsonism and dementia (14, 15) , and we excluded persons who had parkinsonism or dementia or an unknown status for parkinsonism or dementia at the time of their manual dexterity assessment (n = 214). We followed the remaining 4,856 participants until the first of: onset of parkinsonism, onset of dementia, January 1, 2012, or death. At each visit, participants underwent home interviews and medical examinations at the research center. Study followup for neurodegenerative diseases was virtually complete.
The Rotterdam Study has been approved by the medical ethics committee according to the Population Study Act Rotterdam Study, executed by the Ministry of Health, Welfare and Sports of the Netherlands. All participants provided written informed consent to participate in the study.
Assessment of Manual Dexterity
We used the Purdue Pegboard Test (PPT) to assess manual dexterity (16) . In this test, participants are tasked to place as many cylindrical metal pegs into one of 25 holes in a pegboard as possible in 30 seconds. The test is performed thrice, respectively using left hand, right hand, and both hands simultaneously. The average PPT score is calculated as the sum of each trial divided by 3.
Assessment of Covariates
Smoking habits were assessed during home interviews and participants were subsequently categorized as current, former, and never smokers. Also, participants were separately asked for parental history of dementia and parkinsonism. Educational level was also assessed and categorized as primary education, lower/intermediate general education or lower vocational education, intermediate vocational education or higher general education, and higher vocational education or university (17) . Subjective memory complaints were assessed using three questions, which could be answered by yes or no. These questions were as follows: "Do you have more trouble remembering things than before?"; "Does it happen more often that you are on your way to do something and forget what you wanted to do?"; and "Do you more often have trouble finding words during a conversation?" In addition, participants were asked about their preferred hand.
Ascertainment of Dementia and AD
A detailed description of assessment methods has previously been published (18) . In short, participants were screened for dementia at baseline and follow-up examinations using a three-step protocol (15) . Individuals with a positive screen on either Mini-Mental State Examination (MMSE) (19) or the Geriatric Mental Schedule organic level (20) were subjected to the Cambridge Examination for Mental Disorders of the Elderly (21) . Additional information was obtained from routinely performed in-person neuropsychological examination, and the total cohort was continuously monitored for dementia through computerized linkage of medical records from general practitioners and the regional institute for outpatient mental healthcare with the study database. Available neuroimaging data were used when required for establishing a diagnosis. For all suspected cases of dementia, a consensus panel led by a consultant neurologist (P.J.K.) decided on the final diagnosis in accordance with standard criteria for dementia (DSM-III-R), AD (NINCDS-ADRDA), and vascular dementia (NINDS-AIREN). Participants were diagnosed with PD dementia if diagnosis of dementia was preceded by a diagnosis of PD at least 1 year prior.
Assessment of Parkinsonism and PD
A detailed description of assessment methods has previously been published (22) . In short, we used four overlapping modalities to screen for potential parkinsonism: in-person examinations (on average every 4 years), in-person interviews, use of antiparkinson medication, and clinical monitoring alerts. In-person examinations comprised two phases. The screening phase included standardized, bilateral assessments of tremor (resting, positional, and intentional), hypo-and bradykinesia (including arm swing, gait, finger tapping, and general impression), cogwheel rigidity, and postural reflex. Persons who screened positive were invited for a structured physical examination by a research physician specialized in neurologic diseases.
Of all persons who screened positive in any of these methods, complete medical records (including letters from medical records of specialists and general practitioners) were studied and case reports were drawn up covering all potentially relevant information to establish presence and cause of parkinsonism. These case reports were evaluated by a panel led by an experienced neurologist. PD was only diagnosed after exclusion of secondary causes, and medical records of all incident parkinsonism cases (both PD and secondary) continued to be scrutinized until the end of the study period for new information that could lead to a revision of the diagnosis.
Statistical Analysis
Analyses included all participants who were free of dementia and parkinsonism at baseline. We used competing risk models to determine the association of PPT scores with any incident neurodegenerative disease, any dementia, cause-specific dementia (AD and non-AD), any parkinsonism, and cause-specific parkinsonism (PD and non-PD) (23) . For any neurodegenerative disease, death was the only competing risk; for any dementia, death and parkinsonism were competing risks (and vice versa for parkinsonism); for cause-specific neurodegenerative diseases, death and other neurodegenerative diseases were competing risks. All analyses were adjusted for age, sex, comprising education, parental history of neurodegenerative diseases, subjective memory complaints, smoking, and MMSE. In order to facilitate clinical interpretation of our results, we report hazard ratios per decreasing point of average PPT score.
We performed several sensitivity analyses on the association between manual dexterity and any neurodegenerative disease. First, we investigated the association between average PPT score and any incident neurodegenerative disease after excluding at baseline persons with any parkinsonian sign (any hypo-or bradykinesia, tremor, cogwheel rigidity, or postural instability) and, separately, excluding persons with MMSE score less than 26. Second, we consecutively assessed interaction by age, sex, and study subcohort by introducing interaction terms with PPT scores into the main model. After initial analyses showed strong effect modification by age, we stratified further association analyses by age, using the median age as cutoff. Third, we excluded the first 5 years of follow-up to assess whether manual dexterity was associated with long-term risk of neurodegenerative diseases. Fourth, we explored practical implementation of the PPT in clinical practice by using cutoffs of the average PPT score (−1 SD), which allows for a direct comparison of persons with low versus normal/high scores. Fifth, we investigated separate associations of scores on each PPT task (ie, left hand, right hand, and bimanual) with incident neurodegenerative diseases.
Furthermore, we assessed whether the average PPT score improved prediction of any neurodegenerative disease, dementia, and parkinsonism beyond age, sex, study subcohort, education, smoking, preferred hand, parental history, memory complaints, and MMSE. In line with association analyses that showed strong effect modification by age, we stratified prediction analyses by age, using the median age as cutoff. To express the incremental predictive value of manual dexterity assessment, we used markers of risk classification (continuous net reclassification index [NRI] ) and discrimination (integrated discrimination improvement [IDI] and change in concordance statistics [ΔC-statistic]) (24) (25) (26) .
We lacked information on parental history for 1,121 participants (23%) and for less than 2% of participants on all other predictors (education [n = 45], smoking [n = 61], and memory complaints [n = 86]). Missing values were handled by multiple imputation using the mean of five imputations, based on all other predictors and the occurrence of incident neurodegenerative disease. Distribution of variables was similar before and after imputation. Alpha (type 1 error) was set at .05. Data were handled and analyzed with the IBM SPSS Statistics version 21.0.0.1 (IBM, Somers, NY) and R version 3.2.1.
Results
Baseline characteristics of the study population are shown in Table 1 . The median age was 70 years (range 55-98 years), and there were more women than men. Participants in the second subcohort were generally younger than participants in the first subcohort (Supplementary Table 1 ). The distribution of PPT scores was roughly normal (Supplementary Figure 1) . PPT task scores for left, right, and both hands were moderately correlated, with Pearson's correlation coefficients ranging from .69 to .76 (p < .001 for all pairs), and each task score was highly correlated with the average score (ρ = .88 to ρ = .92, p < .001; Supplementary Table 2 ). For the average PPT scores, 1 SD below the mean corresponded to 10 pins, whereas 2 SDs below the mean was roughly equivalent to 8 pins.
During follow-up (median 9.2 years), 277 participants were diagnosed with a neurodegenerative disease of whom 155 (56%) had AD, 72 (26%) had another primary dementia diagnosis, 33 (12%) had PD, and 17 (6%) had parkinsonism due to other causes. 88% of all incident neurodegenerative disease cases were elderly participants (ie, aged > 70 years), and the distribution of neurodegenerative disease diagnoses in this group was similar to the overall distribution (Supplementary Table 3 ). Among the middle-aged participants, the distribution of neurodegenerative disease diagnoses was markedly different: Primary parkinsonism diseases made up 42% of all neurodegenerative disease diagnoses, and only 21% of all neurodegenerative disease cases had an AD diagnosis. Lower PPT scores were independently associated with a higher risk of incident dementia and incident parkinsonism, and each decreasing point of average PPT score corresponded to a 28% higher hazard of any neurodegenerative disease ( dementia, we observed independent associations for AD (HR = 1.22; 95% CI: 1.06-1.39) as well as any other type of dementia, and the effect estimate was more distinct for the latter (HR = 1.33; 95% CI: 1.14-1.54).
The association between PPT scores and incident neurodegenerative diseases was stronger in middle-aged participants (age < 70 years) than in older participants (p for interaction < .001). Furthermore, although we did not observe statistically significant interaction by gender (p = .09), association with any neurodegenerative disease was more pronounced in women (Table 3) . Of all incident neurodegenerative disease cases, 202 (73%) were participants in the first subcohort. We found no evidence for interaction by subcohort in the main analysis (p = .32). The association between average PPT scores and any neurodegenerative disease was not affected by exclusion of persons with any parkinsonian sign and only mildly by low MMSE scores, and PPT scores remained strongly associated with the incidence of neurodegenerative diseases more than 5 years after PPT assessment. Using a binary cutoff that correspond to an average PPT score of 10 pins, persons with low scores were at distinctly increased risk of neurodegenerative diseases compared with others ( Table 3) . As shown in Supplementary Table 4 , parkinsonism-specific estimates were generally somewhat higher than dementia-specific estimates across several sensitivity analyses.
Incorporation of PPT scores significantly improved discrimination (IDI) of any neurodegenerative disease in middle-aged and elderly persons (Table 4 ). In addition, there were nonsignificant improvements in C-statistics and NRI in both age groups. For parkinsonism, IDI improved significantly in both age groups, whereas NRI improved significantly only in the middle-aged adults. For dementia, NRI increased significantly in elderly adults but not in middleaged adults, whereas IDI increased significantly in middle-aged adults but not in elderly adults. For all outcomes, C-statistics did not improve significantly after incorporation of PPT scores. C-statistics after introduction of PPT scores were 0. 
Discussion
In this prospective, population-based sample with up to 12 years of follow-up, we found that low scores on a brief and objective test of manual dexterity are associated with incident dementia and parkinsonism beyond age, sex, and common risk factors. This highlights the overlap in the preclinical phases of dementia and parkinsonism diseases and suggests that manual dexterity testing may contribute to identifying persons at increased risk of neurodegenerative diseases in the general population.
Before interpreting the results of this study further, a few limitations should be noted. First, our definition of neurodegenerative diseases was limited to dementia and parkinsonism. As a consequence, we did not include a relatively small number of community-dwelling elderly individuals with for instance amyotrophic lateral sclerosis. Second, we lacked histologic confirmation of specific neurodegenerative disease diagnoses, which may have led to some misclassification, in particular for disease subtypes such as Lewy-body dementia. In spite of these limitations, our findings add novel insight on the overlap of dementia and parkinsonism diseases. Despite important differences in clinical presentation between AD and PD, patients with AD often show signs of motoric impairment (27) , and cognitive impairment and dementia are common in patients with PD (28). In addition, prospective studies have recently shown that slow gait, in combination with subjective cognitive complaints, is associated with an increased risk of dementia in community-residing individuals (7, 8) . Manual dexterity requires integration of both cognitive and motor skills (9) (10) (11) , and patients with cognitive impairment are generally impaired in fine and complex hand motor activity compared with healthy elderly persons (29) . Although a previous study showed that a combination of manual dexterity, dynamometry, and a neurological Notes: CI = confidence interval; HR = hazard ratio per point of average Purdue Pegboard Test score; MMSE = Mini-Mental State Examination.
Analyses are adjusted for age, sex, study cohort, education, smoking, preferred hand, parental history of neurodegenerative diseases, memory complaints, and Mini-Mental State Examination.
Parkinsonian signs: hypo-and bradykinesia, tremor, cogwheel rigidity, and postural instability. −1 SD corresponded to an average score of ~10 pins (reference is >−1 SD). examination prospectively predicted worsening MMSE scores in community-dwelling elderly adults (30) , manual dexterity has, to the best of our knowledge, not previously been studied prospectively for its association with incident dementia and parkinsonism in a community-based sample. In patient population samples, manual dexterity predicted onset of dementia in PD patients (10,31), but did not predict conversion to AD in mild cognitive impairment patients (32) .
We hypothesized that mild impairment across a variable combination of cognitive and motoric functions may lead to a moderate decline in manual dexterity, possibly making loss of manual dexterity an early symptom of neurodegenerative disease. We observed that dexterity is strongly associated with the risk of both dementia and parkinsonism, which further supports phenotypical overlap between neurodegenerative diseases and highlights the involvement of motor function in dementia and AD. Whether this overlap reflects shared pathophysiological mechanisms remains subject of debate. Although there is pathologic overlap between AD and PD (33) , there are important differences in traditional risk factor profiles, including discordant prospective associations of smoking and serum uric acid with AD and PD (34) (35) (36) (37) . In addition, only relatively little genetic overlap between AD and PD has been identified to date (38) , suggesting that various traditional and genetic risk factors may lead to similar pathology and symptomatology via different pathways (39) . Therefore, we hypothesize that low PPT scores may be a consequence of synucleinopathy, tauopathy, amyloidosis, or vascular lesions, and there may be overlap of these pathologies in at least a subgroup of clinical neurodegenerative disease patients. However, further research is warranted to disentangle the genetic, pathological, and clinical overlap in cognitive and motoric impairment and their progression to neurodegenerative diseases.
Some caution is warranted in the interpretation of our results. For instance, we observed that the overall association of manual dexterity with incident neurodegenerative diseases was somewhat stronger in middle-aged persons than in elderly people. This may be explained by a different distribution of neurodegenerative disease diagnoses in the former, especially the low proportion of AD cases, as well as by a lower prevalence of mild nonneurodegenerative disability that could influence PPT scores independently of brain function, such as locomotor diseases. Still, we note that the number of cases among middle-aged participants was small. Furthermore, while we observed that PPT scores were distinctly associated with incident neurodegenerative diseases independent of traditional risk factors, improvements in markers of prediction were generally relatively small and some of these changes were nonsignificant. In addition, while we assessed the predictive value of PPT scores over subjective memory complaints and MMSE scores, there are several more detailed cognitive and motoric assessments which have higher predictive value for dementia (6) . Also, because we did not perform baseline gait speed assessments in this cohort, we could unfortunately not assess the incremental predictive value of PPT scores for neurodegenerative diseases over gait speed. In a previous study, persons with abnormal baseline gait had worse manual dexterity (4) . Future studies that prospectively investigate gait speed and manual dexterity as risk factors for dementia in one population can formally compare their predictive value and may unravel whether gait speed and manual dexterity reflect the same pathological process or different pathological processes in preclinical dementia.
As of yet, no disease-modifying treatments are available for dementia, which may in part be due to diagnosis at advanced disease stages. The need to assess treatment efficacy at an early, presymptomatic stage of disease has led to discussion about (genetic) screening of asymptomatic participants for neuroprotective trials. Trials have recently been designed for persons with rare, highly risk-increasing traits for AD and PD, both genetic (40) and nongenetic (eg, REM sleep behavior disorder (41)). Although these trials are important to determine the modifiability of disease progression in these subgroups of high-risk persons, a large proportion of prediagnostic AD and PD patients do not possess these rare traits (42) (43) (44) . As a consequence, results from these trials may not be applicable to the majority of patients with neurodegenerative disease. Therefore, it will be vital to have effective community-wide screening programs for neurodegenerative diseases that identify the majority of future clinical neurodegenerative disease patients at an early stage.
In our population-based sample, AD and PD made up 56 and 12% of all incident neurodegenerative disease diagnoses, respectively, whereas 32% had a different dementia or parkinsonism diagnosis. Therefore, combined screening for dementia and parkinsonism, rather than separate screening algorithms for AD and PD, may not only be time saving but also allow detection of one third of future neurodegenerative disease patients who might otherwise be missed. As a first step to identify persons at increased risk of neurodegenerative diseases, community-wide screening programs may comprise basic demographics, a short interview for common risk factors and rapid, consulting room tests such as gait speed and manual dexterity assessment. Persons of AD, PD, and other neurodegenerative diseases could be referred to geriatric or neurologic clinics for refined risk stratification and possibly for suitability for neuroprotective trials. We showed that impaired manual dexterity is a risk factor for both dementia and parkinsonism, suggesting that dexterity testing might be part of such a joint screening algorithm.
In conclusion, this study demonstrates that a simple, nonlaboratory test of manual dexterity can help to predict neurodegenerative diseases in the community. This might contribute to identifying Notes: CI = confidence interval; IDI = integrated discrimination improvement; NRI = continuous net reclassification index. The estimates reflect change in prediction of neurodegenerative diseases after addition of average Purdue Pegboard Test scores to a basic model with age, sex, study subcohort, education, smoking, preferred hand, parental history of neurodegenerative diseases, memory complaints, and Mini-Mental State Examination.
people in the community for refined screening and selection of individuals most suitable for neuroprotective intervention trials.
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